New report further demonstrates Ultra-Glo™ Luciferase is less susceptible to compound interference
MADISONResearch results just published in the Journal of Medicinal Chemistry demonstrate the superior performance of Promega Ultra-Glo™ Luciferase. The research, conducted by the NIH Chemical Genomics Center (NCGC), describes Ultra-Glo recombinant luciferase as approximately 90% less susceptible to small molecule inhibition compared to another commercially...